Hims & Hers Health, Inc. (HIMS) has a consensus analyst rating of Hold, based on 19 analysts covering the stock. Of those, 6 recommend buying, 13 recommend holding, and 0 recommend selling.
The analyst consensus price target for HIMS is $29.92, representing a +40.1% upside from the current price of $21.36. Price targets range from a low of $12.50 to a high of $60.00.
